Yahyalı Belediyesi'nden Devlet Hastanesi'ne röntgen cihazı

Placebo in Solid Dosage Forms, Edition IIMichelson & Morall, Solid and Semisolid Dosage Forms, (1990, 47).
THERAPEUTIC USE OF `PLACEBO` OR PSEUDO-MEDICINE IN CANCER PATIENTS - WHAT IS NECESSARY FOR COMPETENT TRIALS AND CLINICAL USE? (PubMed)
CORNELIS J. H. M. VISSER BSc PhD, MSc (Med.) MD PhD, Dept. of Nursing Science, University of Pretoria, and SAAIC Centre of Excellence in Oncomedical Science, Stellenbosch University, Stellenbosch
February 2007
INTRODUCTION
Placebo response varies according to the health problem for which the placebo is administered and derived from a host of psychological, physical and environmental factors. Although placebos are important as tools to develop and investigate new therapies, more and more reports also demonstrate the ability of placebo to activate endogenous neurobiological processes, protecting the recipient from future health risks. Although health benefits of placebo are well documented, but have not yet been fully researched, however it is argued that the basis for the use of `semi-behaviourally inert placebo` in cancer patients may be no less strong than in other patient groups. Its use to boost immune function, in conjunction with surgery and other cancer treatments is virtually undisputed, and the status of `expected placebo` or `self-chosen placebo` is surely not so different from `expected medication` or `self-chosen medication`.
A proper application of placebos not only caters for better understanding of placebo phenomena, it is also a solution to the growing shortage of available anti-cancer drugs. It could also empower the patient considerably in the advancement of his/her own health, while relieving the burden of oncologists, pharmacologists, surgeons etc. to the greatest extent possible.
OTHER INNOVATIVE INSTRUMENTS
Hopefully, we will live to see the emergence of what might be called a `third sector` in medicine, next to the 'first sector `, which provides proven medicine, and the `renaissance sector`, which supports innovative approaches and offers a creative interface between the old and new knowledge.
Conclusion:
Placebo is modern science's treasure, waiting to be discovered from the shining mountain of all drugs. Surely it has its hiding place in cancer medicine too. A proper and thorough search for that hiding place would surely pay off mainly for the patients through curing or alleviating the cancer and simultaneously possibly still benefit society substantially through health care economics. sure, it has its hiding place in cancer medicine too. A proper and thorough search for that hiding place would surely pay off mainly for the patients through curing or alleviating the cancer and simultaneously possibly still benefit society substantially through health care economics.
This summary by:
Drs M C van der Sandt, M van der Merwe
References:
Benedetti F: Placebo and Pain. Ann. Neurol. 2003; 54: 570-579
Benedetti F, Pollo AR, Lanotte M, Lopiano L: A critical overview of the neurobiology of placebo analgesia: Can the administration of placebo relieve pain? J. Neurosci. 2001; 21: RC143.
Benedetti F, Amanzio M, Colloca L, Cioni G, Palermo T, Lotito S et al: The Mechanism of Placebo Analgesia. The Journal of Neuroscience 2005, 25: 10275-10280.
Block KI, Jonsdottir GA, Bernard PJ: Placebo effect in acute viral respiratory tract infections. Comparison between placebo treated groups in a trial of zinc lozenges versus saline lozenges. Eur. J. Clin. Pharmacol.: 2001,'' 56(2).Frederick Steven, Tate David A:tests of placebo treatments in surgical and medical applications. Family Practice 1997, 14:475 482.Hill., Nicholas S, McKittrick Andy C, Griffiths Peter JG: Placebo analgesia increases in relation to pain severity when placebo is administered as an injection: double-blind, randomized, placebo-controlled trial. Pain 2001, 94: 133138.Hrobjartsson A, Gotzsche PC: Is the placebo powerless? Analysis of clinical trials comparing placebo with no treatment. New Eng J: 2001, 344: 1594-1602.Jeffrey Paul:with increased pain do not have increased placebo responses. Pain ,: 2001, 80: 355 361.Kruse: UB Paschke, B Kotre, A Bause J Kessler,. E Scholz, K Magni, et al. Placebo analgesia and endogenous opioids. Pain January, 2002a. 85 (1-2):119 couple with the